Study | Total number of patients in study | Patient response categorya | Age category (age restrictions)b | GnRH agonist, GnRH antagonist or both | Insemination technique | Starting dose | Stimulation day (r-hLH initiated) | |
---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | r-hFSH (IU) | r-hLH (IU) |  |
Williams 2000 [47] | 60 | Normal | None | Agonist | IVF/ICSI | 300 | 25 | Â |
MS8839 [48] | 76 | Normal | None | Agonist | IVF | 150 | 75 | 1 |
MS9032 [49] | 45 | Normal | None | Agonist | ICSI | c | 75 | 1 |
MS9029 [50] | 42 | Poor | None | Agonist | ICSI | 450 | 75 | 1 |
Balasch 2001 [51] | 30 | Normal | None | Agonist | IVF/ICSI | 450 | 75 | 1 |
MS9640 [52] | 141 | Normal | None | Agonist | IVF/ICSI | 225 | 75 | 1 |
Lisi 2002a [53] | 453 | Poor | None | Agonist | IVF | 225 | 75 | 7 |
Lisi 2002b [54] | 22 | Normal | None | Agonist | IVF/ICSI | 150 | 75 | 7 |
De Moustier 2002 [55] | 169 | Normal | Advanced | Agonist | IVF | 225 | c | Â |
Ludwig 2003 [56] | 20 | Normal | None | Antagonist | IVF/ICSI | Â | 75 | Â |
Sauer 2004 [57] | 42 | Normal | None | Antagonist | ICSI | 225 | 150 | 7 |
Cedrin-Durnerin 2004 [58] | 203 | Normal | None | Antagonist | IVF/ICSI | c | 75 | Â |
Ferraretti 2004 [10] | 108 | Poor | None | Agonist | IVF/ICSI | c | c | Â |
Humaidan 2004 [23] | 231 | Normal | Two subgroups | Agonist | IVF/ICSI | c | c | 8 |
Marrs 2004 [25] | 431 | Normal | Two subgroups | Agonist | ICSI | 225 | 150 | 6 |
Motta 2005 [27] | 102 | Poor | None | Both | IVF/ICSI | Â | 75 | Â |
Griesinger 2005 [59] | 127 | Normal | None | Antagonist | IVF/ICSI | 150 | 75 | 1 |
Demirol 2005 [60] | 106 | Poor | None | Antagonist | ICSI | 450 | 150 | 1 |
De Placido 2005 [61] | 130 | Poor | None | Agonist | IVF/ICSI | 225 | 150 | 8 |
Tarlatzis 2006 [62] | 114 | Normal | None | Agonist | IVF/ICSI | 150 | 75 | Â |
Ramirez 2006 [63] | 34 | Poor | None | Antagonist | IVF/ICSI | c | 150 | Â |
Levi-Setti 2006 [64] | 40 | Normal | None | Antagonist | ICSI | 225 | 75 | Â |
Abdelmassih 2006 [65] | 206 | Normal | None | Agonist | IVF/ICSI | 225 | 75 | 7 |
Aytac 2006 [66] | 35 | Poor | None | Agonist | ICSI | Â | 150 | Â |
Fabregues 2006 [67] | 120 | Normal | Advanced | Agonist | IVF/ICSI | c | 150 | 6 |
Ruvolo 2007 [68] | 42 | Poor | None | Agonist | IVF/ICSI | 225 | c | 8 |
Polidoropoulos 2007 [69] | 136 | Poor | None | Agonist | ICSI | 450 | 75 | Â |
Berkkanoglu 2007 [70] | 97 | Normal | None | Agonist | ICSI | 600 | 75 | 7 |
Nyboe Andersen 2008 [24] | 526 | Normal | Two subgroups | Agonist | IVF/ICSI | c | c | 7 |
Barrenetxea 2008 [71] | 84 | Poor | Advanced | Agonist | ICSI | 375 | 150 | 6 |
Pezzuto 2010 [72] | 80 | Normal | None | Agonist | ICSI | c | 75 | 6 |
Brunet 2009 [73] | 94 | Poor | None | Agonist | IVF | Â | 75 | 8 |
Gutman 2009 [74] | 20 | Normal | None | Agonist | IVF/ICSI | c | 75 | Â |
Matorras 2009 [75] | 131 | Normal | Advanced | Agonist | ICSI | c | 150 | 6 |
Lahoud 2010 [76] | 103 | Normal | None | Agonist | IVF/ICSI | Â | 75 | 7 |
Kovacs 2010 [77] | 50 | Normal | None | Agonist | IVF/ICSI | 150 | 75 | 1 |
Wiser 2011 [78] | 30 | Normal | None | Antagonist | IVF/ICSI | c | 75 | Â |
Musters 2012 [79] | 244 | Poor | Advanced | Agonist | IVF/ICSI | c | c | 1 |
Caserta 2011 [80] | 999 | Normal | None | Agonist | ICSI | 150 | 75 | 7 |
Bosch 2011 [26] | 720 | Normal | Two subgroups | Antagonist | IVF/ICSI | c | 75 | 6 |
Total | 6443 | Â | Â | Â | Â | Â | Â | Â |